Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:24:55 EDT Thu 25 Jun 2026
Enter Symbol
or Name
USA
CA



Q:PLSE - PULSE BIOSCIENCES INC - https://investors.pulsebiosciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PLSE - Q0.121.60·26.630.125.60    28.53  12.56Jun 24Jun 1015 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-06-10 07:00U:PLSENews ReleasePulse Biosciences, Inc. Announces Planned Redemption of Warrants
2026-05-27 16:05U:PLSENews ReleasePulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
2026-05-12 07:00U:PLSENews ReleaseATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million
2026-05-08 07:00U:PLSENews ReleasePulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
2026-05-04 07:00U:PLSENews ReleasePulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
2026-04-25 13:00U:PLSENews ReleasePulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse(TM) Cardiac Catheter System at Heart Rhythm 2026
2026-04-20 07:00U:PLSENews ReleasePulse Biosciences' nPulse(TM) Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
2026-04-17 07:00U:PLSENews ReleasePulse Biosciences to Host Analyst Event on April 25, 2026
2026-04-09 07:00U:PLSENews ReleasePulse Biosciences Strengthens Executive Leadership Team
2026-04-07 07:00U:PLSENews ReleasePulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse(TM) Cardiac Catheter System for Atrial Fibrillation
2026-04-02 16:05U:PLSENews ReleasePulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
2026-03-17 07:00U:PLSENews ReleasePulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
2026-03-12 07:00U:PLSENews ReleasePulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse(TM) Technology
2026-03-09 07:00U:PLSENews ReleasePulse Biosciences Announces Clinical Data From nPulse(TM) Vybrance(TM) System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
2026-03-05 07:00U:PLSENews ReleasePulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
2026-03-04 07:00U:PLSENews ReleasePulse Biosciences' nPulse(TM) Vybrance(TM) System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
2026-02-20 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-02-20 07:00U:PLSENews ReleasePulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
2026-02-19 16:05U:PLSENews ReleasePulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
2026-02-05 19:00U:PLSENews ReleasePulse Biosciences Presents Late-Breaking Data from nPulse(TM) Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium